India Exchange Filings

Board Meeting Highlights and Q2 FY27 Results

Anupam Rasayan India Ltd approves Q2 FY27 results, with consolidated revenue of ₹805.9 crore and net profit of ₹65.0 crore

  • Consolidated revenue rose 10.2% YoY and 23.0% QoQ; net profit increased 13.7% YoY and 26.9% QoQ.
  • Standalone revenue was ₹397.2 crore and net profit was ₹45.7 crore.
  • Consolidated results include Bliss GVS Pharma from its acquisition date, September 28, 2026; auditor’s limited-review conclusions were unmodified.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.